SYNGULON
0521.816.349 · rovalta.com · 25/09/2026
OPENING OF BANKRUPTCY
SYNGULON
Company — Opening of bankruptcy.
Financial year 2023 · Closed on 31/12/2023
Net result-720,8 k €+27,7 %over 1 year
Gross margin142,8 k €+2 167,1 %over 1 year
Equity2,5 M €+3,2 %over 1 year
Workforce9,0 ETP-11,8 %over 1 year
Overview
Identity
Source · BCE/KBOSYNGULON is a Public limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Seraing. It employs on average 9,0 ETP workers (FTE).
- Legal situation
- Opening of bankruptcy
- BCE/KBO no. / VAT
- BE 0521.816.349
- Incorporation
- 07/03/2013
- Legal form
- Public limited company
- Registered office
- Rue du Bois St-Jean 15/1
4102 Seraing · WallonieSee on map - Contributed capital
- 3 246 000,00 €
- Latest accounts
- 31/12/2023
- Average workforce
- 9,0 ETP
Activities (NACE)
Joint committees (1)
- 207
Signals
Solid equity
Financials
Source · NBB, 10 filingsTrend over 10 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 142,8 k € | +2167% | -6,9 k € | -115% | 45,4 k € | +124% | -186,7 k € | -112% | 1,5 M € |
| EBITDA | -575,5 k € | +31.8% | -844,1 k € | -46.9% | -574,5 k € | +22.4% | -740,1 k € | -184% | 881,4 k € |
| Operating result | -676,1 k € | +28.5% | -945,4 k € | -40.0% | -675,2 k € | +19.7% | -840,8 k € | -201% | 828,7 k € |
| Net result | -720,8 k € | +27.7% | -996,7 k € | -38.8% | -718,1 k € | +17.4% | -869 k € | -207% | 809,3 k € |
| Balance sheet | |||||||||
| Equity | 2,5 M € | +3.2% | 2,4 M € | -23.2% | 3,2 M € | -5.4% | 3,4 M € | -20.5% | 4,2 M € |
| Total assets | 5,7 M € | +2.7% | 5,5 M € | -11.7% | 6,2 M € | +12.6% | 5,5 M € | -1.1% | 5,6 M € |
| Cash | 11,4 k € | +660% | 1,5 k € | -99.7% | 538,1 k € | +58609% | 916,6 € | -19.5% | 1,1 k € |
| Debts | 1,9 M € | -3.9% | 2 M € | +14.5% | 1,7 M € | +17.4% | 1,5 M € | +69.1% | 868,2 k € |
| Other | |||||||||
| Workforce | 9,0 ETP | -11.8% | 10,2 ETP | +13.3% | 9,0 ETP | +12.5% | 8,0 ETP | +33.3% | 6,0 ETP |
Board of directors
Source · NBB, accounts to 31/12/2023Other companies at this address
Rue du Bois St-Jean 15/1 4102 Seraing| Company | CBE no. |
|---|---|
ALIZES PHARMA● Active | 1040.385.871 |
ALPHACOMSOLUTION● Active | 0767.826.066 |
AQUILON PHARMACEUTICALS● Active | 0540.870.218 |
AQUITEC PHARMA● Active | 1040.385.970 |
ARTESIA ENVIRONNEMENT● Active | 0688.592.706 |
| 0820.385.022 |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 19/07/2024 | 14/07/2023 | 04/07/2022 | 15/07/2021 | 29/06/2020 | 08/07/2019 |
| General meeting | 27/06/2024 | 28/06/2023 | 29/06/2022 | 30/06/2021 | 24/06/2020 | 26/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2023 | 27/06/2024 | 19/07/2024 | French | |
| Abridged model | 31/12/2022 | 28/06/2023 | 14/07/2023 | French | |
| Abridged model | 31/12/2021 | 29/06/2022 | 04/07/2022 | French | |
| Abridged model | 31/12/2020 | 30/06/2021 | 15/07/2021 | French | |
| Abridged model | 31/12/2019 | 24/06/2020 | 29/06/2020 | French | |
| Abridged model | 31/12/2018 | 26/06/2019 | 08/07/2019 | French | |
| Abridged model | 31/12/2017 | 27/06/2018 | 03/07/2018 | French | |
| Abridged model | 31/12/2016 | 28/06/2017 | 30/06/2017 | French | |
| Abridged model | 31/12/2015 | 29/06/2016 | 05/07/2016 | French | |
| Abridged model | 31/12/2014 | 24/06/2015 | 05/08/2015 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2023Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Capital / shares25/01/2024CAPITAL, ACTIONS
- Mandates07/08/2023DEMISSIONS, NOMINATIONS
- Capital / shares06/03/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates28/09/2022DEMISSIONS, NOMINATIONS
- Capital / shares07/06/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Capital / shares06/01/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates22/07/2021DEMISSIONS, NOMINATIONS
- Mandates20/09/2019DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023-720,8 k €↑
- 2022Annual accounts 2022-996,7 k €↓
- 2021Annual accounts 2021-718,1 k €↑
- 2020Annual accounts 2020-869 k €↓
- 2019Annual accounts 2019809,3 k €↑
- 2018Annual accounts 2018-695,2 k €↓
- 2017Annual accounts 2017-542,9 k €↑
- 2016Annual accounts 2016-590,7 k €↓
- 2015Annual accounts 2015-293,8 k €↑
- 2014Annual accounts 2014-553,5 k €
- 07/03/2013IncorporationPublic limited company